CHRU de Brest, Hopital Morvan, Institut de Cancerologie et d'Hematologie

Brest 29609

0 studies enrolling now · 3 studies all time

What they study most

Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Triple Negative Breast Cancer

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed